Benign Prostatic Hyperplasia: Strategic Growth and Market Evolution
The Benign Prostatic Hyperplasia (BPH) surgical treatment market is undergoing a significant transformation. Once defined by a narrow range of invasive interventions, it is now being reshaped by minimally invasive technologies, shifting patient demographics, and rising global healthcare investment. For C-suite executives and industry leaders, this market represents not just a clinical advancement—but...